Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction

This publication has 24 references indexed in Scilit:

• In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.
  The Journal of Experimental Medicine, 1990
• Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor
  International Immunology, 1990
• Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.
  The Journal of Experimental Medicine, 1989
• The Regulators of Complement Activation (RCA) Gene Cluster
  Published by Elsevier ,1989
• Immunobiology of CR2, the B Lymphocyte Receptor for Epstein-Barr Virus and the C3d Complement Fragment
  Annual Review of Immunology, 1988
• Epstein-barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis
  Cell, 1987
• Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells
  Nature, 1985
• Structural heterogeneity of the C3b/C4b receptor (Cr 1) on human peripheral blood cells.
  The Journal of Experimental Medicine, 1983
• Epstein-Barr virus co-reconstituted with sendai virus envelopes infects Epstein-Barr virus-receptor negative cells
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1981
• Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
  Journal of the American Chemical Society, 1963